SOLIRIS (Alexion Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the SOLIRIS drug offered from Alexion Pharmaceuticals Inc.. This Complement Inhibitor [EPC],Complement Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Alexion Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | ECULIZUMAB |
| SUBSTANCE NAME: | ECULIZUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Complement Inhibitor [EPC],Complement Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2007-04-02 |
| END MARKETING DATE: | 0000-00-00 |
SOLIRIS HUMAN PRESCRIPTION DRUG Details:
| Item Description | SOLIRIS from Alexion Pharmaceuticals Inc. |
| LABELER NAME: | Alexion Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300(mg/30mL) |
| START MARKETING DATE: | 2007-04-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 25682-001_0fb572bf-8c29-405e-bdc3-708e2d6d1c36 |
| PRODUCT NDC: | 25682-001 |
| APPLICATION NUMBER: | BLA125166 |
Other ECULIZUMAB Pharmaceutical Manufacturers / Labelers:
